Exploring the $35 Insulin Cap and Inflation Reduction Act Impact
TL/DR -
Under new initiatives, Medicare Part D and Part B now cap the cost of a one-month supply of insulin at $35, with no deductible needed. This change is part of President Biden’s Inflation Reduction Act, which aims to reduce the price of medication by targeting price gouging and allows Medicare to directly negotiate drug prices, capping the…